State of New Jersey v. Thomas J. Dinapoli

New Jersey Superior Court Appellate Division·Decided January 28, 2025·No. A-1374-23/A-2164-23·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited. R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NO. A-1374-23

A-2164-23

STATE OF NEW JERSEY, Plaintiff-Appellant,

v. THOMAS J. DINAPOLI,

Defendant-Respondent.

Argued September 30, 2024 – Decided January 28, 2025 Before Judges Sabatino and Gummer.

On appeal from an interlocutory order of the Superior Court of New Jersey, Law Division, Union County, Indictment No. 23-07-0473.

James C. Brady, Assistant Prosecutor, argued the cause for appellant (William A. Daniel, Union County Prosecutor, attorney; James C. Brady, of counsel and on the briefs).

Timothy R. Smith argued the cause for respondent (Caruso Smith Picini, PC, attorneys; Timothy R. Smith, of counsel; Zinovia H. Stone, on the briefs).

PER CURIAM In this alleged vehicular-homicide case, the State on leave appeals from two orders entered by the trial court: one denying the State's motion to preclude the testimony of defendant's three expert witnesses and one granting defendant's motion to preclude the testimony of the State's forensic toxicologist regarding defendant's alleged use of or impairment by cocaine or benzoylecgonine (BZE). 1 Perceiving no abuse of discretion or legal error, we affirm the order precluding in part the testimony of the State's expert. However, we vacate the order admitting defendant's expert witnesses and remand the case for a pretrial hearing concerning those witnesses pursuant to N.J.R.E. 104.

I.

At approximately 3:44 p.m. on June 4, 2019, a Mazda driven by defendant was traveling east when it crossed the street's double yellow lines and struck a westbound Chevrolet. An analysis of a sample of defendant's blood taken over four hours after the crash indicated the presence of 7-aminoclonazepam, which is a metabolite of the prescription drug Clonazepam, and BZE, which is a metabolite of cocaine.

1 We consolidated these back-to-back appeals for purposes of issuing a single opinion.

A-1374-23

Michelina Mele was one of the passengers in the Chevrolet. After the crash, Mele was transported and subsequently admitted to a hospital. She was described as being "conscious but confused" and having pain in her chest and leg. Scans and x-rays taken after the crash showed fractures to Mele's ribs and patella and lung contusions. Mele was ninety-four years old and had a history of dementia and Alzheimer's disease; she was deemed a poor candidate for surgery. She had an advance directive for health care instructing that life- prolonging measures, including respiratory support such as ventilation, should not be initiated if she "experience[d] extreme mental or physical deterioration such that there is no reasonable expectation of recovery or regaining a meaningful quality of life[.]" Family members requested she be placed on "comfort care." Mele was pronounced dead on June 5, 2019, at 5:45 p.m. After performing an autopsy, Dr. Beverly Leffers, the county medical examiner, concluded Mele's cause of death was "blunt impact injuries" sustained in an "accident."

On January 8, 2020, a grand jury returned an indictment, charging defendant with one count of second-degree vehicular homicide, N.J.S.A. 2C:11- 5(a) and two counts of fourth-degree assault by auto, N.J.S.A. 2C:12-1(c)(2). A grand jury subsequently issued a superseding indictment, charging defendant

A-1374-23

with the original three charges as well as third-degree strict liability vehicular homicide, N.J.S.A. 2C:11-5.3(a), and third-degree witness tampering, N.J.S.A. 2C:28-5(a).

Before trial, defendant produced reports authored by Marc Polimeni, M.D., an internist, and Robert J. Pandina, Ph.D., a psychologist. The trial judge denied the State's motion to preclude the testimony of Dr. Pandina and reserved on the motion to preclude the testimony of Dr. Polimeni, pending a N.J.R.E. 104 hearing.

Defendant's first trial ended in a mistrial, for reasons not pertinent here, after several witnesses had testified during the State's case in chief, including Dr. Sabeen Khan, Mele's treating physician, and Dr. Leffers. In her testimony during an N.J.R.E. 104 hearing, Dr. Leffers confirmed she had found "blunt impact injuries" as the cause of Mele's death and that "accident" was the manner of death. She opined Mele's injuries "taken together . . . with her preexisting condition were life threatening." In her testimony, Dr. Khan stated "do not resuscitate" (DNR) and "do not intubate" instructions had been put in place regarding Mele "after [a] discussion with [her] son at bedside." Dr. Khan opined Mele's pulse oxygen level had dropped "[m]ost likely from the trauma . . . to her chest wall" caused by the crash. She concluded the trauma to her lungs caused

A-1374-23

Mele's death, and but for the crash, Mele would not have died when she did. Donna Papsun, the State's expert witness in forensic toxicology, testified during two N.J.R.E. 104 hearings regarding the admissibility of her opinions and testimony concerning serological evidence. The trial judge denied defendant's motions to preclude her testimony, and Papsun testified before the jury.

After the mistrial, defendant produced reports from Dr. Polimeni, Dr.

Pandina, and Dr. Henry Velez, an internist and pulmonologist. Dr. Polimeni had been asked to review Mele's cause of death. He opined that none of the injuries she had sustained in the crash were life threatening and that she had been placed on hospice care due to her Alzheimer's disease and not the injuries she had sustained in the crash. He believed she had been "treated appropriately for" hospice care. He concluded Mele had died from the Alzheimer's disease, a terminal illness and a natural cause of death. In his August 1, 2023 report, Dr. Pandina focused on "the impact of medications administered during the course of treatment" and concluded Mele's "physiological processes and functionality . . . . were significantly compromised because of the actions of narcotic medications administered to her during her treatment at [the] hospital on June 4 and 5, 2019." Dr. Pandina also indicated "no advanced directive was in place" while Mele was a patient at the hospital and questioned "why staff placed her

A-1374-23

on DNR status" and "abandoned" "life sustain[ing] efforts." In his report, Dr. Velez acknowledged the existence of an advance directive and that she had received treatment "consistent with the goals of hospice." However, he opined her "poor prognosis" was "overstated" and "it was more probable than not, that if Ms. Mele had not been placed on hospice care, and if she had not suffered respiratory depression and hypoxia due to the use of opioids," Mele "most probably would have survived the injuries of her accident." He concluded the "motor vehicle accident was not the proximate cause of her death."

In September 2023, defendant moved to preclude the testimony of Papsun related to defendant's use of cocaine and Clonazepam. That same day, the State moved to preclude the testimony of Drs. Velez, Polimeni, and Pandina on the grounds that their opinions contradicted accepted medical standards and were legally impermissible under the model jury charge for causation.

After hearing argument, the trial court denied the State's motion and requested supplemental submissions regarding defendant's motion, stating it would "reserve . . . and [would] wait to hear when [defendant's expert witnesses] testify . . . to see whether they're qualified to testify in the area that they are offered for." The State asked the court to conduct a pretrial hearing regarding the qualifications of defendant's expert witnesses; the court denied that request.

A-1374-23

Free access — add to your briefcase to read the full text and ask questions with AI

State of New Jersey v. Thomas J. Dinapoli, (N.J. Ct. App. 2025).

State of New Jersey v. Thomas J. Dinapoli (State of New Jersey v. Thomas J. Dinapoli) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Gonzalez v. Ideal Tile Importing Co.
877 A.2d 1247 (Supreme Court of New Jersey, 2005)
State v. Pelham
824 A.2d 1082 (Supreme Court of New Jersey, 2003)
State v. Martin
573 A.2d 1359 (Supreme Court of New Jersey, 1990)
Gonzalez v. Ideal Tile Importing Co.
853 A.2d 298 (New Jersey Superior Court App Division, 2004)
State v. Eldridge
909 A.2d 736 (New Jersey Superior Court App Division, 2006)
Carey v. Lovett
622 A.2d 1279 (Supreme Court of New Jersey, 1993)
State v. Nesbitt
888 A.2d 472 (Supreme Court of New Jersey, 2006)
State v. Marrero
691 A.2d 293 (Supreme Court of New Jersey, 1997)
People v. Funes
23 Cal. App. 4th 1506 (California Court of Appeal, 1994)
State v. Coruzzi
460 A.2d 120 (New Jersey Superior Court App Division, 1983)
Deborah Townsend v. Noah Pierre (072357)
110 A.3d 52 (Supreme Court of New Jersey, 2015)
State v. K.P.S. and State v. Carmini Laloo
112 A.3d 579 (Supreme Court of New Jersey, 2015)
State v. Julie Kuropchak
113 A.3d 1174 (Supreme Court of New Jersey, 2015)
State v. Anthony K. Cole (076255) (Middlesex and Statewide)
163 A.3d 302 (Supreme Court of New Jersey, 2017)
State v. Abella.
454 P.3d 482 (Hawaii Supreme Court, 2019)
Nicholas v. Hackensack Univ. Med. Ctr.
192 A.3d 16 (New Jersey Superior Court App Division, 2018)
Alloco v. Ocean Beach & Bay Club
192 A.3d 24 (New Jersey Superior Court App Division, 2018)
State v. Buckley
78 A.3d 958 (Supreme Court of New Jersey, 2013)
Stribling v. State
818 S.E.2d 563 (Supreme Court of Georgia, 2018)
In re Accutane Litig.
191 A.3d 560 (Supreme Court of New Jersey, 2018)